With the continuous development of economy, population aging is becoming more and more obvious. Under the strategic plan of "healthy China", we believe that medical industry in China will face a vast development opportunity in future. Patient's expectation towards medical services is rising in dignositc and treatment field. Thus, more accurate diagnosis and better treatment regime is also aspired by physicians. It represents potential opportunities for both pharmaceuticals/ devices company and other medical service providers

At the same time, higher and higher pressure of reimbursement, differentiated role of each tier hospitals under hierarchical medical system, much faster R&D and launch of innovation drugs, new diagnosis and treatment model like patient centric, penetration and revolution of Internet, big data and diagnostic techniques, all indicate development of Chinese medical market will be very complicated

On the one hand, we need deep understanding of external market trend and evolution, on the other hand, we strongly believe that the needs of good medical service of physicians and patients keep stable at all times. Based on this principle, we commit ourselves to become a research institution who can deeply understand physicians’ work and patients’ needs. Through rich professional research experience on disease diagnosis and treatment, increasing sophistication and advanced research method, we provide market insight to help pharmaceutical/device enterprises and new medical service providers, better understanding physicians and patients’ needs. More superior decisions will be made based on those insights.